Study reveals hyperimmune intravenous immunoglobulin doesn't help COVID-19 patientsThe combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remde...
28 Jan, 2022, 11.59 AM IST
European stocks bounce off lows on virus treatment hopesThe pan-European STOXX 600 index rose 1.3%, mirroring gains for Asian markets after the U.S. health regulator said on Sunday it authorized ...
24 Aug, 2020, 03.01 PM IST
Scientists are now testing if survivor plasma can prevent Covid-19Thousands of coronavirus patients in hospitals around the world have been treated with so-called convalescent plasma.
12 Jun, 2020, 06.17 PM IST
- Sanofi plans mega US deal to counter sales dip
Sanofi-Aventis, France’s biggest drugmaker, is preparing a major acquisition in the US, according to five people with knowledge of the situ...
03 Jul, 2010, 01.12 AM IST
- Spain's Grifols plans to buy Talecris for $3.4 bn
Spanish health care company Grifols plans to expand in the U.S. with the $3.4 billion purchase of plasma company Talecris Biotherapeutics.
08 Jun, 2010, 07.19 AM IST